Table 2

Variables associated with survival on univariable and multivariable analyses in 1620 patients with colon and 1243 patients with rectal cancer, by tumor location

Univariable analyses
ColonRectum
FactorP valueFactorP value
DFSOSDSSOSDSS
Age<0.001<0.0010.03Male0.001
T stage<0.0010.001Age<0.001<0.001
N stage<0.001T stage<0.001<0.001
M stage<0.001<0.001N stage<0.001<0.001
TNM stage<0.001<0.001<0.001M stage<0.001<0.001
Histologic grade<0.001<0.001TNM stage<0.001<0.001
VI<0.001<0.001Histologic grade<0.001<0.001
LVI<0.001VI<0.001<0.001
HLA-B/C0.01<0.001LVI0.02
KRAS0.02
CEA<0.001<0.001
HLA-B/C<0.001<0.001
Multivariable analyses
ColonRectum
Factor
P valueFactor
P value
DFSOSDSSOSDSS
Study0.0010.0010.03Study<0.001<0.001
Age<0.001<0.001Age<0.001<0.001
TNM stage<0.001<0.001<0.001TNM stage<0.001<0.001
Histologic grade<0.001<0.001Histologic grade<0.001<0.001
HLA-B/C0.006<0.001HLA-B/C<0.001
  • DFS is not shown for rectal tumors since only one study provided such data. P values derived from log-rank test and Cox regression models for univariable and multivariable analyses, respectively.

  • CEA, carcinoembryonic antigen; DFS, disease-free survival; DSS, disease-specific survival; HLA, human leucocyte antigen; LVI, lymphovascular invasion; OS, overall survival; TNM, tumor, node, metastasis; VI, vascular invasion.